Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M324Revenue $M8.0Net Margin (%)-551.8Z-Score-2.5
Enterprise Value $M199EPS $-1.8Operating Margin %-550.0F-Score4
P/E(ttm))0Cash Flow Per Share $-0.8Pre-tax Margin (%)-551.8Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %0Quick Ratio3.7Cash flow > EarningsY
Price/Sales20.05-y EBITDA Growth Rate %-15.7Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-53.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)6ROE % (ttm)-81.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M61.9ROI % (ttm)-81.5Gross Margin Increase y-yN

Gurus Latest Trades with XNPT

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
XNPTJohn Burbank 2014-06-30 Buy $3.28 - $5.22
$ 5.1923%New holding, 17817 sh.17,817
XNPTPRIMECAP Management 2012-06-30 Buy $4.08 - $6.15
$ 5.191%New holding, 125000 sh.125,000
XNPTGeorge Soros 2011-12-31 Sold Out -0.0016%$3.57 - $6.34
$ 5.194%Sold Out0
XNPTGeorge Soros 2011-09-30 Reduce$5.95 - $7.72
$ 5.19-26%Reduce -38.17%16,200
XNPTGeorge Soros 2011-06-30 Buy $6.05 - $9.31
$ 5.19-31%New holding, 26200 sh.26,200
XNPTLee Ainslie 2010-03-31 Sold Out -0.39%$6.67 - $20.55
$ 5.19-64%Sold Out0
XNPTLee Ainslie 2009-12-31 Add0.07%$15.5 - $21.42
$ 5.19-70%Add 21.23%1,877,364
XNPTLee Ainslie 2008-12-31 Buy 0.73%$17.18 - $41.61
$ 5.19-83%New holding, 1417100 sh.1,417,100
XNPTGeorge Soros 2006-09-30 Sold Out -0.13%$16.66 - $21.92
$ 5.19-73%Sold Out0
XNPTGeorge Soros 2006-06-30 Buy 0.13%$16.94 - $24.79
$ 5.19-76%New holding, 53893 sh.53,893
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XNPT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
XNPT John Burbank 2014-06-3017,8170.030New Buy
XNPT PRIMECAP Management 2014-06-30104,0000.170-18.75%
Premium Most recent portfolio changes are included for Premium Members only!

XNPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BATES GREGORY TSVP, Regulatory Affairs & QA 2014-09-09Sell5,612$5.26-1.14view
Freund John GordonDirector 2014-06-03Buy12,500$3.9332.32view
WIERENGA WENDALLDirector 2014-05-27Buy10,000$3.9930.33view
FRIEDMAN CATHYDirector 2014-05-27Buy2,600$3.9232.65view
FENTON DENNIS MDirector 2014-05-27Buy3,000$4.0229.35view
Freund John GordonDirector 2014-05-23Buy15,000$3.7339.41view
Barrett Ronald WCEO 2014-05-23Buy2,600$3.7538.67view
MARIO ERNESTDirector 2014-05-23Buy30,000$3.7339.41view
BERNS PAUL LDirector 2014-05-15Sell2,500$3.6642.08view
BERNS PAUL LDirector 2014-04-24Sell2,500$4.320.93view

Press Releases about XNPT :

    Quarterly/Annual Reports about XNPT:

      News about XNPT:

      Articles On GuruFocus.com
      comment on XNPT Mar 15 2013 
      comment on XNPT Mar 06 2013 
      XenoPort Inc. Reports Operating Results (10-Q) Nov 09 2010 
      XenoPort Inc. Reports Operating Results (10-Q) Aug 06 2010 
      XenoPort Inc. Reports Operating Results (10-Q) May 10 2010 
      Xenoport - A Shaking Ham Hock Feb 07 2010 
      XenoPort Inc. Reports Operating Results (10-Q) Aug 06 2009 
      XenoPort Reports Second Quarter Financial Results Aug 05 2009 
      Weekly Top Insider Buys: Alcoa Inc., ABM Industries Inc., Valhi Inc., XenoPort Inc., and Methode Ele Jul 11 2009 
      XenoPort Inc. Reports Operating Results (10-Q) May 07 2009 

      More From Our Partners
      Xenoport/NIAAA Collaborate on Alcoholism Therapy - Analyst Blog Sep 10 2014 - ZACKS

      More From Other Websites
      XenoPort And NIAAA To Test Alcoholism Treatment Sep 10 2014
      Xenoport/NIAAA Collaborate on Alcoholism Therapy Sep 10 2014
      XenoPort to Present Data for Novel Fumarate Analog XP23829 at the 2014 Joint ACTRIMS-ECTRIMS Meeting... Sep 10 2014
      XenoPort and the NIAAA Announce Clinical Trial Agreement to Study HORIZANT as a Potential Treatment... Sep 09 2014
      XenoPort to Present at the Morgan Stanley Global Healthcare Conference Sep 02 2014
      XENOPORT INC Financials Aug 15 2014
      XENOPORT INC Files SEC form 10-Q, Quarterly Report Aug 07 2014
      XENOPORT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 06 2014
      XenoPort Reports Second Quarter Financial Results Aug 06 2014
      Q2 2014 XenoPort, Inc. Earnings Release - After Market Close Aug 06 2014
      XenoPort to Release Second Quarter Financial Results on August 6, 2014 Jul 22 2014
      Immune Pharma: A Top-Pick Based On Pipeline And Valuation Jul 09 2014
      XenoPort entitled to $20M upfront payment on license pact Jun 24 2014
      XENOPORT INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial... Jun 24 2014
      XenoPort's XP23829 in Phase II Study Jun 24 2014
      XENOPORT INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 16 2014
      Stockholders Elect ALL Three XenoPort Director Nominees at Annual Meeting Jun 11 2014
      XenoPort to Present at the 2014 Wells Fargo Healthcare Conference Jun 09 2014
      XenoPort Urges Stockholders to Vote "FOR ALL" XenoPort Director Nominees on the WHITE Proxy Card Jun 06 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial